Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 246.02% | 84.34% | -261.32% | 249.51% | 14.68% |
| Total Depreciation and Amortization | -10.73% | -10.76% | -4.12% | -23.15% | -1.97% |
| Total Amortization of Deferred Charges | 0.53% | -19.72% | -5.72% | 24.25% | 12.69% |
| Total Other Non-Cash Items | -785.71% | -95.38% | 228.02% | -290.57% | -19.49% |
| Change in Net Operating Assets | -13.62% | 118.50% | 503.41% | -31.66% | 1,762.01% |
| Cash from Operations | 16.15% | 287.59% | 183.75% | -394.09% | 141.64% |
| Capital Expenditure | -12.40% | -101.60% | -37.16% | -207.47% | 7.75% |
| Sale of Property, Plant, and Equipment | 493.80% | -84.56% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.50% | -- | 100.00% | -12,490.00% | 39.39% |
| Cash from Investing | -7.46% | -112.66% | -27.98% | -224.53% | 7.82% |
| Total Debt Issued | -- | -- | -- | -- | 36.31% |
| Total Debt Repaid | -18.83% | 98.30% | -619.89% | 67.28% | 94.84% |
| Issuance of Common Stock | 362.81% | 206.59% | 36.84% | -91.05% | 92.24% |
| Repurchase of Common Stock | -346.68% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 47.96% |
| Cash from Financing | -309.62% | 83.24% | -656.84% | -100.70% | 228.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.07% | -8.96% | 15.10% | -123.71% | 272.17% |